Center-Authored Papers

Filters: Author is Parry, Susan  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
Win AK, Parry S, Parry B, Kalady MF, Macrae FA, Ahnen DJ, Young GP, Lipton L, Winship I, Boussioutas A et al..  2013.  Risk of Metachronous Colon Cancer Following Surgery for Rectal Cancer in Mismatch Repair Gene Mutation Carriers.. Annals of surgical oncology. 20(6):1829-1836. Abstract
Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I et al..  2012.  Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.. Journal of the National Cancer Institute. 104(18):1363-72. Abstract
Win AK, Dowty JG, Antill YC, English DR, Baron JA, Young JP, Giles GG, Southey MC, Winship I, Lipton L et al..  2011.  Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers.. Obstetrics and gynecology. 117(4):899-905. Abstract
Win AK, Hopper JL, Buchanan DD, Young JP, Tenesa A, Dowty JG, Giles GG, Goldblatt J, Winship I, Boussioutas A et al..  2013.  Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers? European journal of cancer (Oxford, England : 1990). 49(7):1578-87. Abstract
Win AK, Lindor NM, Winship I, Tucker KM, Buchanan DD, Young JP, Rosty C, Leggett B, Giles GG, Goldblatt J et al..  2013.  Risks of colorectal and other cancers after endometrial cancer for women with lynch syndrome.. Journal of the National Cancer Institute. 105(4):274-9. Abstract
Win AK, Dowty JG, Cleary SP, Kim H, Buchanan DD, Young JP, Clendenning M, Rosty C, MacInnis RJ, Giles GG et al..  2014.  Risk of Colorectal Cancer for Carriers of Mutations in MUTYH, with and without a Family History of Cancer.. Gastroenterology. Abstract
Walsh MD, Buchanan DD, Cummings MC, Pearson S-A, Arnold ST, Clendenning M, Walters R, McKeone DM, Spurdle AB, Hopper JL et al..  2010.  Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(7):2214-24. Abstract
R
Rosty C, Clendenning M, Walsh MD, Eriksen SV, Southey MC, Winship IM, Macrae FA, Boussioutas A, Poplawski NK, Parry S et al..  2016.  Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort.. BMJ open. 6(2):e010293. Abstract
Roberts A, Nancarrow D, Clendenning M, Buchanan DD, Jenkins MA, Duggan D, Taverna D, McKeone D, Walters R, Walsh MD et al..  2011.  Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome).. Familial cancer. 10(2):245-54. Abstract
P
Parry S, Win AK, Parry B, Macrae FA, Gurrin LC, Church JM, Baron JA, Giles GG, Leggett BA, Winship I et al..  2011.  Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery.. Gut. 60(7):950-7. Abstract
O
Obermair A, Youlden DR, Young JP, Lindor NM, Baron JA, Newcomb PA, Parry S, Hopper JL, Haile R, Jenkins MA.  2010.  Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma.. International journal of cancer. Journal international du cancer. 127(11):2678-84. Abstract
J
Jayasekara H, Reece JC, Buchanan DD, Rosty C, Dashti GS, Ouakrim DA, Winship IM, Macrae FA, Boussioutas A, Giles GG et al..  2016.  Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study.. International journal of cancer. Abstract
G
Goodenberger MKL, Thomas BC, Riegert-Johnson D, Boland RC, Plon SE, Clendenning M, Win AK, Senter L, Lipkin SM, Stadler ZK et al..  2016.  PMS2 monoallelic mutation carriers: the known unknown.. Genetics in medicine : official journal of the American College of Medical Genetics. 18(1):13-19. Abstract
D
Dowty JG, Win AK, Buchanan DD, Lindor NM, Macrae FA, Clendenning M, Antill YC, Thibodeau SN, Casey G, Gallinger S et al..  2013.  Cancer Risks for MLH1 and MSH2 Mutation Carriers.. Human mutation. 34(3):490-7. Abstract
Dashti GS, Buchanan DD, Jayasekara H, Ouakrim DA, Clendenning M, Rosty C, Winship IM, Macrae FA, Giles GG, Parry S et al..  2016.  Alcohol Consumption and the Risk of Colorectal Cancer in Mismatch Repair Gene Mutation Carriers.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
C
Cicek MS, Cunningham JM, Fridley BL, Serie DJ, Bamlet WR, Diergaarde B, Haile RW, Le Marchand L, Krontiris TG, Younghusband BH et al..  2012.  Colorectal Cancer Linkage on Chromosomes 4q21, 8q13, 12q24, and 15q22.. PloS one. 7(5):e38175. Abstract
Chau R, Dashti SG, Ouakrim DA, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Macrae FA et al..  2016.  Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome.. International journal of epidemiology. 45(3):940-953. Abstract
B
Buchanan DD, Win AK, Walsh MD, Walters RJ, Clendenning M, Nagler BN, Pearson S-A, Macrae F, Parry S, Arnold J et al..  2013.  Family History of Colorectal Cancer in BRAF p.V600E mutated Colorectal Cancer Cases.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, English DR, Walsh MD, Clendenning M, McKeone DM, Walters RJ et al..  2010.  Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics.. PloS one. 5(7):e11636. Abstract
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract